Squarepoint
JNP

Squarepoint’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Squarepoint’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-28,100
Closed -$244K – 2374
2018
Q2 		$244K Buy
+28,100
New +$253K ﹤0.01% 1468

Squarepoint's JNP Position: Q3 2018 in Review

Squarepoint sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 28,100 shares — an estimated $244K sold.

Squarepoint first reported a position in JNP in Q2 2018 and held it in 1 quarter. The position peaked at $244K in Q2 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

  • Squarepoint reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Squarepoint sold 28,100 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $244K.
  • Squarepoint first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
  • Squarepoint's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $244K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Squarepoint's 13F filing for Q3 2018, filed 14 Nov 2018.